Our data also revealed the importance of IL‐10 and IL‐6 in predicting metastatic progression, albeit they provide a subleading and fluctuating contribution to melanoma outcome prediction compared to Breslow thickness and serum levels of IL‐4, GM‐CSF, and DCD. The gene discussed is IL6; the disease is melanoma.